Approvals/HSA/NUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 µg/dose (RECOMBINANT, ADJUVANTED)

Approved

STANDARD

NUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 µg/dose (RECOMBINANT, ADJUVANTED)

Unknown🇸🇬 Health Sciences Authority

Approval Id: 2bd4d0210eb53484
Drug Name: NUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 µg/dose (RECOMBINANT, ADJUVANTED)

SARS-CoV-2 recombinant spike protein

5 µg/dose

Approved

Agency

HSA

Country

🇸🇬

Approval Date

Jan 13, 2026

Approval ID

2bd4d0210eb53484

Type

Standard